Oramed Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ORMP Nasdaq 2834 www.oramed.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Oramed Pharmaceuticals Inc.

We're Not Very Worried About Oramed Pharmaceuticals' (NASDAQ:ORMP) Cash Burn Rate - Jun 27th, 2025 4:15 am
The past three years for Oramed Pharmaceuticals (NASDAQ:ORMP) investors has not been profitable - May 17th, 2025 6:45 am
Oramed: Q1 Earnings Snapshot - May 15th, 2025 4:16 pm
WEX, Acelyrin, and More Stocks See Action From Activist Investors - May 9th, 2025 4:18 pm
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical - Apr 28th, 2025 7:00 am
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals - Apr 28th, 2025 7:00 am
ORMP: Upcoming Expected Milestones Include OraTech Spin-Off & IPO, Launch of Phase 3 Trial - Apr 3rd, 2025 3:56 am
Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential - Mar 13th, 2025 11:05 am
Oramed Pharmaceuticals Issues Letter to Shareholders - Mar 4th, 2025 7:00 am
Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch - Feb 11th, 2025 5:11 pm
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin - Feb 11th, 2025 7:15 am
3 US Penny Stocks With Market Caps Above $40M - Dec 4th, 2024 1:12 pm
ORMP: Preparations for New Phase 3 Trial Advance, While ORMP Leverages Balance Sheet Through Recent Agreements - Dec 2nd, 2024 8:09 am
US Penny Stocks To Watch: 3 Picks With Market Caps Over $40M - Nov 5th, 2024 1:04 pm
Scilex Holding Starts $50 Million Registered Direct Offering of Convertible Notes - Oct 7th, 2024 8:50 am
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt - Oct 7th, 2024 8:00 am
ORMP: Balance Sheet Strong, Potential Benefits of Investments, JVs, Buybacks - Aug 29th, 2024 9:29 am
Oramed: Q2 Earnings Snapshot - Aug 15th, 2024 3:12 am
3 Micro-Cap Moonshots for Fearless Investors - Jul 8th, 2024 1:07 pm